Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

A patient perspective on kidney disease in the public health agenda

Nature Reviews Nephrology (2024)Cite this article

Subjects

Chronic kidney disease is a life-changing diagnosis for millions of people worldwide, as the risk of disease progression and kidney failure creates unbearable uncertainty and limits lifestyle. The devastating impact of advanced kidney disease must be acknowledged in the public health agenda to pave way for improved outcomes for patients at all stages of disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kovesdy, C. P. Epidemiology of chronic kidney disease: an update 2022. Kidney Int. Suppl. (2011) 12, 7–11 (2022).

    Article  PubMed  Google Scholar 

  2. World Health Organization. The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (2020).

  3. Benziger, C. P., Roth, G. A. & Moran, A. E. The Global Burden of Disease study and the preventable burden of NCD. Glob. Heart 11, 393–397 (2016).

    Article  PubMed  Google Scholar 

  4. Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392, 2052–2090 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mudiayi, D. et al. Global estimates of capacity for kidney transplantation in world countries and regions. Transplantation 106, 1113–1122 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ruiz, R. & Kirk, A. D. Long-term toxicity of immunosuppressive therapy. In Transplantation of the Liver 3rd edn (eds Busuttil, R. W. & Klintmalm, G. B. G.) 1354–1363 (2015); https://doi.org/10.1016/B978-1-4557-0268-8.00097-X.

  7. Lee, T., Flythe, J. E. & Allon, M. Dialysis care around the world: a global perspectives series. Kidney360 2, 604–607 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Vanholder, J. A. et al. The European Green Deal and nephrology: a call for action by the European Kidney Health Alliance. Nephrol. Dial. Transplant. 38, 1080–1088 (2023).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. European Kidney Patients Federation (EKPF), Vienna, Austria

    Daniel Gallego

  2. Spanish Kidney Patient Federation (ALCER), Madrid, Spain

    Daniel Gallego

Authors
  1. Daniel Gallego
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Gallego.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gallego, D. A patient perspective on kidney disease in the public health agenda. Nat Rev Nephrol (2024). https://doi.org/10.1038/s41581-024-00846-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41581-024-00846-w

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing